Dova Pharmaceuticals: 2Q Earnings Snapshot
DURHAM, N.C. (AP) _ Dova Pharmaceuticals Inc. (DOVA) on Tuesday reported a loss of $17.1 million in its second quarter.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of 60 cents.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.
The pharmaceutical company posted revenue of $3.5 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $5.6 million.
Dova Pharmaceuticals shares have more than doubled since the beginning of the year. The stock has decreased 27% in the last 12 months.